Adam D. Teitcher represents clients in complex commercial cases, including product liability and mass torts, securities and shareholder disputes, consumer class action defense, breach of contract and business torts, and internal investigations. He represents clients in diverse industries including healthcare, real estate, banking, utilities, and telecommunications. Adam’s pro bono experience includes cases involving voting rights, immigration, and civil rights. Prior to joining Morgan Lewis, Adam was a litigation associate at a globally recognized firm.
Representing international pharmaceutical company in action challenging marketing and branding of opioid medications.
Representing national marketplace of home services provider against claims of false advertising and unfair competition.
Represented hedge fund against insider trading claims in multi-billion dollar securities fraud matter.
Obtained favorable results in New York state trial and appellate courts defending business developer’s $400+ million development against opposition group of local and competing businesses.
Pro bono counsel for civic organization in case brought against federal election officials in two states, alleging violations of the Constitution, the National Voter Registration Act, and the Administrative Procedure Act.
Conducted internal investigations on behalf of public companies in response to allegations of possible accounting fraud and in response to requests from the Department
Advised companies of FDA and FAA regulatory compliance.
Fordham University School of Law, 2012, J.D., cum laude
University of Pennsylvania, 2009, B.A., Cognitive Science/Neuroscience, Jewish Studies
US Court of Appeals for the Tenth Circuit
US Court of Appeals for the Ninth Circuit
US District Court for the Central District of California
Summer Law Clerk to Judge Joseph F. Bianco of the US District Court for the Eastern District of New York (June 2010 - August 2010)
Awards and Affiliations
Associate Editor, Fordham Law Review, Vol. 80.
Recommended, Dispute resolution: Product liability, mass tort and class action - defense: pharmaceuticals and medical devices, The Legal 500 US (2022)